Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Adjunct Metformin in Combination With Multidrug Treatment for Multibacillary Leprosy: A Randomized Double-blind, Controlled Proof-of-Concept Phase 2 Trial in Indonesia

NCT05243654 is registered in ClinicalTrials.gov with Oxford University Clinical Research Unit Indonesia as lead sponsor.

NCT NCT05243654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Adjunct Metformin in Combination With Multidrug Treatment for Multibacillary Leprosy: A Randomized Double-blind, Controlled Proof-of-Concept Phase 2 Trial in Indonesia
Lead sponsor
Oxford University Clinical Research Unit Indonesia
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2022
Completion date
September 30, 2026
Enrollment
166 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

leprosy, leprosy, multibacillary, neglected tropical diseases